Climate Tech is hot right now.  Two weeks ago, X-energy priced its IPO at $23 per share -- well above its marketed range of $16 to $19 -- raised $1 billion in an upsized offering, and opened on Nasdaq up 27% on its first day of trading. The company closed at an $11.5 billion valuation. It had $94 million in revenue last year and a $390 million net loss.

Fervo Energy, the enhanced geothermal startup backed by some of Silicon Valley's biggest names, filed for an IPO raising $1.3 billion at a potential $6.5 billion valuation.

What are the IP issues that these companies should be handling to ensure a successful IPO?

What Institutional Investors Actually Check

Institutional investors evaluating a deep tech IPO are focused on five questions:

1. Does the company actually own the core technology? This means complete IP assignment chains from every person who contributed to the foundational innovations -- founders, early employees, contractors, academic collaborators, government research partners. Many deep tech companies have origins in university labs or government-funded research programs where IP assignment is complicated and often incomplete. Those gaps do not disappear at IPO. They get disclosed as risk factors that institutional investors price accordingly.
2. How strong and broad is the patent portfolio? Investors evaluate patent quality on multiple dimensions: claim breadth, prosecution history, whether claims map to the current product and business model, international coverage in key jurisdictions, and how exposed the portfolio is to invalidity challenge. A portfolio built on narrow claims, rushed prosecution, or claims that drifted away from the actual product during development signals IP fragility. Institutional investors know the difference between a filing and a fortress.
3. Are there licensing entanglements that limit commercialization? Tech companies frequently license foundational technology from universities, national laboratories, or prior employers. The terms of those licenses -- exclusivity scope, field-of-use restrictions, milestone payment obligations, sublicensing rights, change-of-control provisions -- determine how freely the company can commercialize and what happens to the license in an acquisition or restructuring. These terms are not just legal details. They directly affect the valuation.
4. What is the freedom-to-operate exposure? In crowded technology fields -- advanced nuclear, geothermal, battery chemistry, carbon capture -- competitors file extensively. An investor who buys a deep tech IPO needs confidence that the company can operate its business without infringing third-party patents. A company that has never conducted a formal freedom-to-operate analysis is carrying undisclosed risk. That risk will either surface as a disclosure obligation or as a litigation threat after the company is public.
5. How is the non-patented competitive advantage protected? For deep tech companies, a meaningful portion of the technological advantage often lives in know-how that cannot or should not be patented -- manufacturing processes, engineering tolerances, operational expertise, data accumulated through deployment. If that know-how is not protected as a trade secret through a documented program with appropriate access controls and confidentiality obligations, it is not protected at all. Institutional investors who understand deep tech understand this distinction.

The Gap Between a Compelling Story and a Credible Offering

Climate tech and deep tech have had a difficult history with public markets. In the first wave of clean energy IPOs, companies went public on compelling stories about technology that was not ready, economics that did not pencil, and IP positions that could not withstand scrutiny. The resulting underperformance -- and in several cases, collapse -- left institutional investors wary of the category for a decade.

What is different now is not just the market appetite. It is the quality of the companies accessing that appetite. X-energy priced above its range and held its gains because it could show institutional investors something specific: a reactor design backed by a patent portfolio developed over more than a decade, a fuel fabrication facility already under construction, signed agreements with Dow and Amazon, and a licensing business model that required acquirers of the technology to pay for the right to use it.

The narrative was compelling. The IP structure made the narrative credible.

That combination -- a powerful market thesis backed by demonstrably owned, demonstrably defensible IP -- is what separates the deep tech IPOs that price at a premium and hold from the ones that price below range and fade. Institutional investors have seen enough of both to know the difference before the roadshow ends.

What This Means for Founders Who Are Not IPO-Ready Yet

Most climate tech and deep tech founders reading this are not three months from an S-1 filing. They are three years away, or five, or they have not decided yet whether a public offering is the right exit path. That is precisely why this moment matters.

The IP work that produces a credible public offering takes years. Patent portfolios require time to build breadth, time to prosecute claims that hold up, time to develop the international coverage that a global technology licensing business requires. Trade secret programs must be established and maintained consistently, courts and institutional investors alike are skeptical of programs that appear to have been assembled in anticipation of a transaction.

The founders who show up to their IPO roadshow with investor-grade IP did not build it in the twelve months before filing. They built it from the beginning, with the discipline and the strategic intent that treating IP as infrastructure, rather than a checkbox or a cost center, actually requires.

The window opening in the public markets is not an opportunity to figure out your IP position. It is a deadline to have already done so.

The Question to Ask Before the Roadshow

When an institutional investor's IP analyst opens your S-1, what will they find?

Will they find a patent portfolio with claims that cover the actual product, not the product you built four years ago, not the product you described in the provisional, but the product you are commercializing today and the roadmap you are taking public? Will they find complete IP assignment chains tracing every core innovation back to the company, with no gaps from university origins, government research programs, or early contractors? Will they find a trade secret program protecting the process know-how that defines your operational advantage? Will they find licensing terms that are clean enough to support the business model you are pitching?

If the answer to any of those questions is uncertain, the work starts now. Not because an IPO is imminent but because the window for doing this work cleanly closes earlier than founders expect.

X-energy priced well above its range because institutional investors looked at its IP position and believed the story. The founders who will follow them through that window will have built the same foundation. The ones who haven't will get a different conversation.

If you are building in climate tech, deep tech, nuclear, geothermal, advanced materials, or any capital-intensive sector where the technology is the entire value proposition, and you have not done a comprehensive IP audit that maps your patent portfolio to your current business model, traces your ownership chain, and identifies your trade secret exposure, you do not know what institutional investors would find.

That is information worth having before they do.